Clinical Trial Update: Stage III NSCLC RWE in Chinese Patients

View source ↗

Summary

This clinical trial update reports completion of real-world evidence evaluating Stage III non-small cell lung cancer in Chinese patients, sponsored by AstraZene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED